NASDAQ: CDTCdt Equity Inc Stock Ownership - Who owns Cdt Equity?
Insider buying vs selling
Have Cdt Equity Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrew Regan | Chief Executive Officer | 2025-12-08 | 224,800 | $1.79 | $402.39kBuy |
| Andrew Regan | Chief Executive Officer | 2025-09-19 | 1,120,000 | $0.69 | $768.32kBuy |
| Andrew Regan | Chief Executive Officer | 2025-06-03 | 154,799 | $3.23 | $500.00kBuy |
| Faith L. Charles | Director | 2025-04-16 | 115,194 | $0.87 | $99.99kBuy |
| Freda C. Lewishall | Director | 2025-03-30 | 47,612 | $0.89 | $42.37kBuy |
| Chele Chiavacci Farley | Director | 2025-03-30 | 32,022 | $0.89 | $28.50kBuy |
| Simon Jeremy Fry | Director | 2025-03-30 | 29,354 | $0.89 | $26.13kBuy |
| Faith L. Charles | Director | 2025-03-30 | 46,629 | $0.89 | $41.50kBuy |
CDT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CDT insiders and whales buy or sell their stock.
CDT Shareholders
What type of owners hold Cdt Equity Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Andrew Regan | 2,817.84% | 45,913,939 | $47.75M | Insider |
| Nirland Ltd | 373.88% | 6,092,000 | $6.34M | Insider |
| Jack Kendrick Heilbron | 292.70% | 4,769,250 | $4.96M | Insider |
| David Tapolczay | 122.95% | 2,003,324 | $2.08M | Insider |
| Sarborg Ltd | 113.78% | 1,853,933 | $1.93M | Insider |
| Murphy Canyon Acquisition Sponsor LLC | 46.27% | 754,000 | $784.16k | Insider |
| Shaolin Capital Management LLC | 37.86% | 616,950 | $641.63k | Insider |
| Freda C. Lewishall | 34.11% | 555,797 | $578.03k | Insider |
| James Bligh | 29.46% | 480,024 | $499.22k | Insider |
| Faith L. Charles | 10.14% | 165,238 | $171.85k | Insider |
CDT vs Biotech Stocks
Cdt Equity Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.